ISSUE: Prescription Drug Affordability

Orange Book Patent Listings

Tracked Litigation

Mylan Pharmaceuticals Inc. et al v. Sanofi-Aventis U.S. LLC et al.

Status: Briefing is ongoing :
Motion to Dismiss Granted in Part and Denied in Part

Date Filed: May 18, 2023

Court: Pennsylvania Western

Goal: Award damages

Teva Branded Pharmaceutical Products R&D LLC. et al. v. Amneal Pharmaceuticals of New York, LLC et al.

Status: Decision issued

Date Filed: June 11, 2024

Court: Federal Circuit

Goal: Block infringement of a patent

Teva Branded Pharmaceutical Products R&D LLC et al v. Amneal Pharmaceuticals of New York, LLC et al

Status: Case dismissed

Date Filed: October 6, 2023

Court: New Jersey

Goal: Block infringement of a patent

Inactive Case

Jazz Pharmaceuticals v. Avadel CNS Pharmaceuticals

Status: CASE DISMISSED

Date Filed: May 12, 2021

Court: Delaware

Goal: Block infringement of a patent

Dive Deeper

O'Neill Institute

Recent Developments in Orange Book Litigation: How Patent Disputes Shape Prescription Drug Affordability

More Issues